These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 33236179)

  • 1. Outcomes and predictors of juvenile idiopathic arthritis in Southeast Asia: a Singapore longitudinal study over a decade.
    Teh KL; Tanya M; Das L; Hoh SF; Gao X; Arkachaisri T
    Clin Rheumatol; 2021 Jun; 40(6):2339-2349. PubMed ID: 33236179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Juvenile idiopathic arthritis in Southeast Asia: the Singapore experience over two decades.
    Tanya M; Teh KL; Das L; Hoh SF; Gao X; Arkachaisri T
    Clin Rheumatol; 2020 Nov; 39(11):3455-3464. PubMed ID: 32418038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sacroiliitis at diagnosis as a protective predictor against disease flare after stopping medication: outcomes of a Southeast Asian enthesitis-related arthritis (ERA) longitudinal cohort.
    Teh KL; Das L; Book YX; Hoh SF; Gao X; Arkachaisri T
    Clin Rheumatol; 2022 Oct; 41(10):3027-3034. PubMed ID: 35794290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort.
    Guzman J; Oen K; Tucker LB; Huber AM; Shiff N; Boire G; Scuccimarri R; Berard R; Tse SM; Morishita K; Stringer E; Johnson N; Levy DM; Duffy KW; Cabral DA; Rosenberg AM; Larché M; Dancey P; Petty RE; Laxer RM; Silverman E; Miettunen P; Chetaille AL; Haddad E; Houghton K; Spiegel L; Turvey SE; Schmeling H; Lang B; Ellsworth J; Ramsey S; Bruns A; Campillo S; Benseler S; Chédeville G; Schneider R; Yeung R; Duffy CM;
    Ann Rheum Dis; 2015 Oct; 74(10):1854-60. PubMed ID: 24842571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes and disease course of children with juvenile idiopathic arthritis in the ReACCh-Out cohort: a two-centre experience.
    Chhabra A; Robinson C; Houghton K; Cabral DA; Morishita K; Tucker LB; Petty RE; Larché M; Batthish M; Guzman J
    Rheumatology (Oxford); 2020 Dec; 59(12):3727-3730. PubMed ID: 32402087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment prescribing patterns in patients with juvenile idiopathic arthritis (JIA): Analysis from the UK Childhood Arthritis Prospective Study (CAPS).
    Davies R; Carrasco R; Foster HE; Baildam EM; Chieng SEA; Davidson JE; Ioannou Y; Wedderburn LR; Thomson W; Hyrich KL
    Semin Arthritis Rheum; 2016 Oct; 46(2):190-195. PubMed ID: 27422803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enthesitis-related arthritis is the most common category of juvenile idiopathic arthritis in Taiwan and presents persistent active disease.
    Shih YJ; Yang YH; Lin CY; Chang CL; Chiang BL
    Pediatr Rheumatol Online J; 2019 Aug; 17(1):58. PubMed ID: 31443722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance.
    Horton DB; Onel KB; Beukelman T; Ringold S
    J Rheumatol; 2017 Mar; 44(3):352-360. PubMed ID: 28148696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Outcomes in Juvenile Idiopathic Arthritis: Eighteen Years of Follow-Up in the Population-Based Nordic Juvenile Idiopathic Arthritis Cohort.
    Glerup M; Rypdal V; Arnstad ED; Ekelund M; Peltoniemi S; Aalto K; Rygg M; Toftedal P; Nielsen S; Fasth A; Berntson L; Nordal E; Herlin T;
    Arthritis Care Res (Hoboken); 2020 Apr; 72(4):507-516. PubMed ID: 30762291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective study on 158 Thai patients with juvenile idiopathic arthritis followed in a single center over a 15-year period.
    Vilaiyuk S; Soponkanaporn S; Jaovisidha S; Benjaponpitak S; Manuyakorn W
    Int J Rheum Dis; 2016 Dec; 19(12):1342-1350. PubMed ID: 26176300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of Flare Following Etanercept Withdrawal in Patients with Rheumatoid Factor-negative Juvenile Idiopathic Arthritis Who Reached Remission while Taking Medication.
    Aquilani A; Marafon DP; Marasco E; Nicolai R; Messia V; Perfetti F; Magni-Manzoni S; De Benedetti F
    J Rheumatol; 2018 Jul; 45(7):956-961. PubMed ID: 29717035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically inactive disease in a cohort of children with new-onset polyarticular juvenile idiopathic arthritis treated with early aggressive therapy: time to achievement, total duration, and predictors.
    Wallace CA; Giannini EH; Spalding SJ; Hashkes PJ; O'Neil KM; Zeft AS; Szer IS; Ringold S; Brunner HI; Schanberg LE; Sundel RP; Milojevic DS; Punaro MG; Chira P; Gottlieb BS; Higgins GC; Ilowite NT; Kimura Y; Johnson A; Huang B; Lovell DJ;
    J Rheumatol; 2014 Jun; 41(6):1163-70. PubMed ID: 24786928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort.
    Guzman J; Oen K; Huber AM; Watanabe Duffy K; Boire G; Shiff N; Berard RA; Levy DM; Stringer E; Scuccimarri R; Morishita K; Johnson N; Cabral DA; Rosenberg AM; Larché M; Dancey P; Petty RE; Laxer RM; Silverman E; Miettunen P; Chetaille AL; Haddad E; Houghton K; Spiegel L; Turvey SE; Schmeling H; Lang B; Ellsworth J; Ramsey SE; Bruns A; Roth J; Campillo S; Benseler S; Chédeville G; Schneider R; Tse SM; Bolaria R; Gross K; Feldman B; Feldman D; Cameron B; Jurencak R; Dorval J; LeBlanc C; St Cyr C; Gibbon M; Yeung RS; Duffy CM; Tucker LB;
    Ann Rheum Dis; 2016 Jun; 75(6):1092-8. PubMed ID: 25985972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of etanercept in children with juvenile idiopathic arthritis below the age of 2 years.
    Windschall D; Müller T; Becker I; Horneff G
    Rheumatol Int; 2015 Apr; 35(4):613-8. PubMed ID: 25208527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis.
    Bava C; Mongelli F; Pistorio A; Bertamino M; Bracciolini G; Dalprà S; Davì S; Lanni S; Muratore V; Pederzoli S; Rosina S; Schiappapietra B; Suffia C; Varnier G; Verazza S; Giancane G; Consolaro A; Ravelli A
    Pediatr Rheumatol Online J; 2019 Jul; 17(1):50. PubMed ID: 31345226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment Withdrawal Following Remission in Juvenile Idiopathic Arthritis: A Systematic Review of the Literature.
    Halyabar O; Mehta J; Ringold S; Rumsey DG; Horton DB
    Paediatr Drugs; 2019 Dec; 21(6):469-492. PubMed ID: 31673960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of children with oligoarticular juvenile idiopathic arthritis compared to polyarthritis on methotrexate- data of the German BIKER registry.
    Raab A; Kallinich T; Huscher D; Foeldvari I; Weller-Heinemann F; Dressler F; Kuemmerle-Deschner JB; Klein A; Horneff G
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):41. PubMed ID: 33752685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of medication withdrawal method on flare-free survival in patients with juvenile idiopathic arthritis on combination therapy.
    Chang CY; Meyer RM; Reiff AO
    Arthritis Care Res (Hoboken); 2015 May; 67(5):658-66. PubMed ID: 25220674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Outcomes Following Achievement of Clinically Inactive Disease in Juvenile Idiopathic Arthritis: The Importance of Definition.
    Shoop-Worrall SJW; Verstappen SMM; McDonagh JE; Baildam E; Chieng A; Davidson J; Foster H; Ioannou Y; McErlane F; Wedderburn LR; Thomson W; Hyrich KL
    Arthritis Rheumatol; 2018 Sep; 70(9):1519-1529. PubMed ID: 29648683
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.